ABL2 and chronic obstructive pulmonary disease: Mechanistically, miR-27a-5p directly targeted ABL2 to regulate inflammatory cytokine release.<h4>Conclusions</h4>MiR-27a-5p within our study was identified as a promising biomarker for COPD susceptibility and modulated airway inflammation via the miR-27a-5p-ABL2 axis.